CIPLAPharmaceuticals

Cipla LtdCash Flow Statement

1242.30
+0.19%

Cipla Ltd Cash Flow Statement (Annual)

Metric20252024202320222021
Free Cash Flow3.46K Cr2.78K Cr2.05K Cr2.62K Cr
Repayment Of Debt-98.01 Cr-300.46 Cr-351.90 Cr-1.04K Cr
Issuance Of Debt11.96 Cr0.000.0070.49 Cr
Issuance Of Capital Stock0.05 Cr0.04 Cr0.07 Cr-2.70 Cr
Capital Expenditure-1.55K Cr-1.35K Cr-1.18K Cr-701.15 Cr
End Cash Position542.65 Cr512.34 Cr561.33 Cr658.11 Cr
Beginning Cash Position512.34 Cr561.33 Cr658.11 Cr790.43 Cr
Effect Of Exchange Rate Changes9.26 Cr5.56 Cr12.37 Cr13.45 Cr
Changes In Cash21.05 Cr-54.55 Cr-109.15 Cr-145.77 Cr
Financing Cash Flow-1.29K Cr-1.20K Cr-958.29 Cr-1.60K Cr
Net Other Financing Charges-40.35 Cr-71.99 Cr-4.27 Cr-19.75 Cr
Interest Paid Cff-36.38 Cr-64.83 Cr-65.00 Cr-75.66 Cr
Cash Dividends Paid-1.05K Cr-686.17 Cr-403.50 Cr-403.35 Cr
Common Stock Dividend Paid-1.05K Cr-686.17 Cr-403.50 Cr-403.35 Cr
Net Common Stock Issuance0.05 Cr0.04 Cr0.07 Cr-2.70 Cr
Common Stock Issuance0.05 Cr0.04 Cr0.07 Cr-2.70 Cr
Net Issuance Payments Of Debt-86.05 Cr-300.46 Cr-351.90 Cr-1.01K Cr
Net Short Term Debt Issuance-98.01 Cr-300.46 Cr-308.00 Cr34.98 Cr
Short Term Debt Payments-98.01 Cr-300.46 Cr-308.00 Cr
Net Long Term Debt Issuance11.96 Cr0.00-43.90 Cr-1.04K Cr
Long Term Debt Issuance11.96 Cr0.000.0070.49 Cr
Investing Cash Flow-3.69K Cr-2.99K Cr-2.39K Cr-1.87K Cr
Net Other Investing Changes25.63 Cr46.60 Cr8.94 Cr26.34 Cr
Interest Received Cfi260.20 Cr208.23 Cr114.01 Cr46.99 Cr
Net Investment Purchase And Sale-2.20K Cr-1.70K Cr-1.35K Cr-1.25K Cr
Sale Of Investment0.000.60 Cr0.00170.64 Cr
Purchase Of Investment-2.20K Cr-1.70K Cr-1.35K Cr-1.42K Cr
Net Business Purchase And Sale-235.72 Cr-222.49 Cr-25.13 Cr-18.02 Cr
Sale Of Business0.00120.40 Cr25.77 Cr0.00
Purchase Of Business-235.72 Cr-342.89 Cr-50.90 Cr-18.02 Cr
Net Intangibles Purchase And Sale-377.49 Cr-251.05 Cr-323.50 Cr-153.26 Cr
Sale Of Intangibles8.55 Cr0.0018.86 Cr3.78 Cr
Purchase Of Intangibles-386.04 Cr-251.05 Cr-342.36 Cr-157.04 Cr
Net PPE Purchase And Sale-1.14K Cr-1.06K Cr-812.01 Cr-527.71 Cr
Sale Of PPE24.85 Cr34.17 Cr28.52 Cr16.40 Cr
Purchase Of PPE-1.16K Cr-1.10K Cr-840.53 Cr-544.11 Cr
Operating Cash Flow5.00K Cr4.13K Cr3.24K Cr3.33K Cr
Taxes Refund Paid-1.67K Cr-1.60K Cr-1.30K Cr-1.14K Cr
Change In Working Capital-665.47 Cr-806.10 Cr-559.42 Cr-177.46 Cr
Change In Payable458.94 Cr162.71 Cr-18.21 Cr362.29 Cr
Change In Inventory-322.54 Cr-61.86 Cr110.77 Cr-621.11 Cr
Change In Receivables-801.87 Cr-906.95 Cr-651.98 Cr81.36 Cr
Other Non Cash Items-227.87 Cr-161.51 Cr-69.66 Cr15.37 Cr
Stock Based Compensation47.34 Cr46.16 Cr39.04 Cr24.12 Cr
Provisionand Write Offof Assets8.93 Cr23.51 Cr-36.68 Cr-40.82 Cr
Depreciation And Amortization995.45 Cr1.05K Cr1.02K Cr990.08 Cr
Amortization Cash Flow266.45 Cr237.87 Cr314.17 Cr306.52 Cr
Depreciation729.00 Cr1.05K Cr705.02 Cr683.56 Cr
Gain Loss On Investment Securities-408.82 Cr-291.18 Cr-143.07 Cr-79.25 Cr
Net Foreign Currency Exchange Gain Loss-13.85 Cr-22.81 Cr-56.20 Cr11.15 Cr
Gain Loss On Sale Of PPE5.06 Cr-3.49 Cr-1.58 Cr-8.68 Cr
Gain Loss On Sale Of Business0.00-0.93 Cr0.000.00
Net Income From Continuing Operations6.82K Cr5.90K Cr4.22K Cr3.68K Cr
Long Term Debt Payments0.00-43.90 Cr-1.04K Cr-1.02K Cr
Dividends Received Cfi0.000.01 Cr21.64 Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.